(HBAN) Huntington Bancshares - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4461501045
Stock: Banking, Lending, Investments, Insurance, Payments
Total Rating 29
Risk 51
Buy Signal -0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 32.6% |
| Relative Tail Risk | -7.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | -6.57 |
| Character TTM | |
|---|---|
| Beta | 1.005 |
| Beta Downside | 1.720 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.01% |
| CAGR/Max DD | 0.40 |
EPS (Earnings per Share)
Revenue
Description: HBAN Huntington Bancshares March 05, 2026
Huntington Bancshares Incorporated is a bank holding company. It provides commercial, consumer, and mortgage banking services through its subsidiary, The Huntington National Bank. Regional banks typically focus on a specific geographic area.
The company offers a range of financial products. These include deposits, various lending options, payment solutions, and investment management. Its business model encompasses both direct and indirect consumer loans, as well as specialized services like dealer finance and private banking.
HBAN also provides digitally-powered financial solutions. These cater to consumer finance, regional banking, branch banking, and wealth management clients. The banking sector increasingly emphasizes digital offerings.
Additional services include equipment financing, asset-based lending, and municipal financing. It also provides corporate risk management and capital markets services. For further research, ValueRay can provide detailed financial data and historical trends.
Products are delivered via branches, ATMs, online and mobile banking, and call centers. This multi-channel approach serves various customer segments, including middle market and corporate banking clients.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 2.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.19 > 1.0 |
| NWC/Revenue: -954.6% < 20% (prev -1152 %; Δ 197.5% < -1%) |
| CFO/TA 0.01 > 3% & CFO 2.38b > Net Income 2.21b |
| Net Debt (16.70b) to EBITDA (3.08b): 5.41 < 3 |
| Current Ratio: 0.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.57b) vs 12m ago 6.34% < -2% |
| Gross Margin: 61.70% > 18% (prev 0.58%; Δ 6112 % > 0.5%) |
| Asset Turnover: 5.82% > 50% (prev 5.86%; Δ -0.04% > 0%) |
| Interest Coverage Ratio: 0.48 > 6 (EBITDA TTM 3.08b / Interest Expense TTM 4.32b) |
Altman Z'' -3.29
| A: -0.53 (Total Current Assets 27.91b - Total Current Liabilities 147.10b) / Total Assets 225.11b |
| B: 0.03 (Retained Earnings 6.35b / Total Assets 225.11b) |
| C: 0.01 (EBIT TTM 2.06b / Avg Total Assets 214.67b) |
| D: 0.02 (Book Value of Equity 4.46b / Total Liabilities 200.73b) |
| Altman-Z'' Score: -3.29 = D |
Beneish M
| DSRI: none (Receivables none/7.58b, Revenue 12.48b/11.96b) |
| GMI: 0.94 (GM 61.70% / 58.23%) |
| AQI: 1.00 (AQ_t 0.87 / AQ_t-1 0.87) |
| SGI: 1.04 (Revenue 12.48b / 11.96b) |
| TATA: -0.00 (NI 2.21b - CFO 2.38b) / TA 225.11b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of HBAN shares?
As of March 07, 2026, the stock is trading at USD 16.31 with a total of 27,475,121 shares traded.
Over the past week, the price has changed by -2.92%, over one month by -15.36%, over three months by -2.87% and over the past year by +11.98%.
Over the past week, the price has changed by -2.92%, over one month by -15.36%, over three months by -2.87% and over the past year by +11.98%.
Is HBAN a buy, sell or hold?
Huntington Bancshares has received a consensus analysts rating of 4.24.
Therefore, it is recommended to buy HBAN.
- StrongBuy: 12
- Buy: 3
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HBAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.7 | 26.9% |
| Analysts Target Price | 20.7 | 26.9% |
HBAN Fundamental Data Overview March 06, 2026
P/E Trailing = 12.1079
P/E Forward = 10.3413
P/S = 4.4412
P/B = 1.5732
P/EG = 1.8799
Revenue TTM = 12.48b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 3.08b USD
Long Term Debt = 17.22b USD (from longTermDebt, last quarter)
Short Term Debt = 1.26b USD (from shortTermDebt, last quarter)
Debt = 18.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.70b USD (from netDebt column, last quarter)
Enterprise Value = 24.73b USD (34.16b + Debt 18.48b - CCE 27.91b)
Interest Coverage Ratio = 0.48 (Ebit TTM 2.06b / Interest Expense TTM 4.32b)
EV/FCF = 10.92x (Enterprise Value 24.73b / FCF TTM 2.27b)
FCF Yield = 9.16% (FCF TTM 2.27b / Enterprise Value 24.73b)
FCF Margin = 18.14% (FCF TTM 2.27b / Revenue TTM 12.48b)
Net Margin = 17.71% (Net Income TTM 2.21b / Revenue TTM 12.48b)
Gross Margin = 61.70% ((Revenue TTM 12.48b - Cost of Revenue TTM 4.78b) / Revenue TTM)
Gross Margin QoQ = 63.17% (prev 62.33%)
Tobins Q-Ratio = 0.11 (Enterprise Value 24.73b / Total Assets 225.11b)
Interest Expense / Debt = 5.81% (Interest Expense 1.07b / Debt 18.48b)
Taxrate = 17.12% (108.0m / 631.0m)
NOPAT = 1.70b (EBIT 2.06b * (1 - 17.12%))
Current Ratio = 0.19 (Total Current Assets 27.91b / Total Current Liabilities 147.10b)
Debt / Equity = 0.76 (Debt 18.48b / totalStockholderEquity, last quarter 24.34b)
Debt / EBITDA = 5.41 (Net Debt 16.70b / EBITDA 3.08b)
Debt / FCF = 7.37 (Net Debt 16.70b / FCF TTM 2.27b)
Total Stockholder Equity = 21.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.03% (Net Income 2.21b / Total Assets 225.11b)
RoE = 10.06% (Net Income TTM 2.21b / Total Stockholder Equity 21.99b)
RoCE = 5.25% (EBIT 2.06b / Capital Employed (Equity 21.99b + L.T.Debt 17.22b))
RoIC = 4.52% (NOPAT 1.70b / Invested Capital 37.73b)
WACC = 7.93% (E(34.16b)/V(52.64b) * Re(9.62%) + D(18.48b)/V(52.64b) * Rd(5.81%) * (1-Tc(0.17)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.38%
[DCF] Terminal Value 77.09% ; FCFF base≈2.03b ; Y1≈1.87b ; Y5≈1.68b
[DCF] Fair Price = 6.75 (EV 30.40b - Net Debt 16.70b = Equity 13.70b / Shares 2.03b; r=7.93% [WACC]; 5y FCF grow -9.89% → 2.90% )
EPS Correlation: -6.16 | EPS CAGR: 3.95% | SUE: -0.74 | # QB: 0
Revenue Correlation: 89.49 | Revenue CAGR: 18.95% | SUE: 3.08 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.38 | Chg7d=-0.005 | Chg30d=-0.031 | Revisions Net=-7 | Analysts=17
EPS current Year (2026-12-31): EPS=1.46 | Chg7d=-0.012 | Chg30d=-0.022 | Revisions Net=-11 | Growth EPS=+4.8% | Growth Revenue=+38.5%
EPS next Year (2027-12-31): EPS=1.89 | Chg7d=-0.026 | Chg30d=-0.030 | Revisions Net=-5 | Growth EPS=+29.8% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -0.64 (2 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.6% - Earnings Yield 8.3%)
[Growth] Growth Spread = +44.7% (Analyst 46.1% - Implied 1.4%)
P/E Forward = 10.3413
P/S = 4.4412
P/B = 1.5732
P/EG = 1.8799
Revenue TTM = 12.48b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 3.08b USD
Long Term Debt = 17.22b USD (from longTermDebt, last quarter)
Short Term Debt = 1.26b USD (from shortTermDebt, last quarter)
Debt = 18.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.70b USD (from netDebt column, last quarter)
Enterprise Value = 24.73b USD (34.16b + Debt 18.48b - CCE 27.91b)
Interest Coverage Ratio = 0.48 (Ebit TTM 2.06b / Interest Expense TTM 4.32b)
EV/FCF = 10.92x (Enterprise Value 24.73b / FCF TTM 2.27b)
FCF Yield = 9.16% (FCF TTM 2.27b / Enterprise Value 24.73b)
FCF Margin = 18.14% (FCF TTM 2.27b / Revenue TTM 12.48b)
Net Margin = 17.71% (Net Income TTM 2.21b / Revenue TTM 12.48b)
Gross Margin = 61.70% ((Revenue TTM 12.48b - Cost of Revenue TTM 4.78b) / Revenue TTM)
Gross Margin QoQ = 63.17% (prev 62.33%)
Tobins Q-Ratio = 0.11 (Enterprise Value 24.73b / Total Assets 225.11b)
Interest Expense / Debt = 5.81% (Interest Expense 1.07b / Debt 18.48b)
Taxrate = 17.12% (108.0m / 631.0m)
NOPAT = 1.70b (EBIT 2.06b * (1 - 17.12%))
Current Ratio = 0.19 (Total Current Assets 27.91b / Total Current Liabilities 147.10b)
Debt / Equity = 0.76 (Debt 18.48b / totalStockholderEquity, last quarter 24.34b)
Debt / EBITDA = 5.41 (Net Debt 16.70b / EBITDA 3.08b)
Debt / FCF = 7.37 (Net Debt 16.70b / FCF TTM 2.27b)
Total Stockholder Equity = 21.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.03% (Net Income 2.21b / Total Assets 225.11b)
RoE = 10.06% (Net Income TTM 2.21b / Total Stockholder Equity 21.99b)
RoCE = 5.25% (EBIT 2.06b / Capital Employed (Equity 21.99b + L.T.Debt 17.22b))
RoIC = 4.52% (NOPAT 1.70b / Invested Capital 37.73b)
WACC = 7.93% (E(34.16b)/V(52.64b) * Re(9.62%) + D(18.48b)/V(52.64b) * Rd(5.81%) * (1-Tc(0.17)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.38%
[DCF] Terminal Value 77.09% ; FCFF base≈2.03b ; Y1≈1.87b ; Y5≈1.68b
[DCF] Fair Price = 6.75 (EV 30.40b - Net Debt 16.70b = Equity 13.70b / Shares 2.03b; r=7.93% [WACC]; 5y FCF grow -9.89% → 2.90% )
EPS Correlation: -6.16 | EPS CAGR: 3.95% | SUE: -0.74 | # QB: 0
Revenue Correlation: 89.49 | Revenue CAGR: 18.95% | SUE: 3.08 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.38 | Chg7d=-0.005 | Chg30d=-0.031 | Revisions Net=-7 | Analysts=17
EPS current Year (2026-12-31): EPS=1.46 | Chg7d=-0.012 | Chg30d=-0.022 | Revisions Net=-11 | Growth EPS=+4.8% | Growth Revenue=+38.5%
EPS next Year (2027-12-31): EPS=1.89 | Chg7d=-0.026 | Chg30d=-0.030 | Revisions Net=-5 | Growth EPS=+29.8% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -0.64 (2 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.6% - Earnings Yield 8.3%)
[Growth] Growth Spread = +44.7% (Analyst 46.1% - Implied 1.4%)